[Circulating immune complexes and myasthenia gravis (analysis of 78 cases)]

Area of Science:

• Immunology
• Clinical Medicine

Context:

• Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
• Circulating immune complexes (CIC) are implicated in various autoimmune diseases.
• Understanding CIC in MG is crucial for disease management.

Purpose:

• To investigate the presence and levels of circulating immune complexes (CIC) in patients with myasthenia gravis (MG).
• To assess the correlation between CIC titres and the clinical status of MG patients.
• To evaluate the potential of CIC as a biomarker for disease activity and treatment response.

Summary:

• The study analyzed CIC in 78 myasthenia gravis patients using the C3b sensitized with yeast cell (C3bSYCA) agglutination assay.
• Anti-human C3 ELISA was employed for a subset of patients, detecting IgG and IgM CIC.
• A high positivity rate of 82% for CIC was observed.
• CIC titres demonstrated a significant decrease correlating with clinical improvement in MG patients.

Impact:

• Circulating immune complexes (CIC) can serve as a valuable referential index for monitoring myasthenia gravis (MG) clinical condition.
• CIC measurements can aid in evaluating the effectiveness of therapeutic interventions in MG.
• This research highlights CIC's role in identifying immune aberrations associated with MG.